A Novel Nonsense Mutation in the Fumarate Hydratase Gene in a Chinese Patient with Recurrent Leiomyomas

Overview

Journal F S Rep

Specialty Reproductive Medicine

Date 2024 Jan 11

PMID 38204953

Authors

Yiyin Ruan

Weiwei Feng

Chenmin Yang

Affiliations

Soon will be listed here.

Abstract

Objective: To describe a novel nonsense mutation in the fumarate hydratase (FH) gene in a Chinese patient with recurrent multiple leiomyomas.

Design: Case report.

Setting: Medical school-affiliated tertiary hospital.

Patients: A nulligravida patient aged 30 years with large uterine leiomyomas (ULMs) and severe anemia.

Interventions: Clinical evaluation, abdominal myomectomy, targeted next-generation sequencing.

Main Outcome Measures: Fumarate hydratase gene mutation in ULMs.

Results: A novel nonsense mutation (c.771T>G) in the gene was identified in this patient. This mutation is located in exon 6, which encodes the N-terminal fumarate lyase domain. It leads to a predicted truncated protein with loss of the majority of the lyase domain, resulting in FH deficiency.

Conclusions: Because of the recurrent multiple leiomyomas, this patient received 2 myomectomies within 5 years. On immunostaining the leiomyoma, FH deficiency was detected, and targeted next-generation sequencing revealed a novel mutation of the gene. This patient was at risk for early disease relapse and developing renal cancer, and close disease monitoring is recommended. Meanwhile, the expanded mutation database should benefit patients in diagnosing gene-associated ULMs.

References

Toro J, Nickerson M, Wei M, Warren M, Glenn G, Turner M . Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet. 2003; 73(1):95-106. PMC: 1180594. DOI: 10.1086/376435. View

Alam N, Olpin S, Leigh I . Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol. 2005; 153(1):11-7. DOI: 10.1111/j.1365-2133.2005.06678.x. View

Schmidt C, Sciacovelli M, Frezza C . Fumarate hydratase in cancer: A multifaceted tumour suppressor. Semin Cell Dev Biol. 2019; 98:15-25. PMC: 6974395. DOI: 10.1016/j.semcdb.2019.05.002. View

Patel V, Handler M, Schwartz R, Lambert W . Hereditary leiomyomatosis and renal cell cancer syndrome: An update and review. J Am Acad Dermatol. 2017; 77(1):149-158. DOI: 10.1016/j.jaad.2017.01.023. View

Siegler L, Erber R, Burghaus S, Brodkorb T, Wachter D, Wilkinson N . Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening. Virchows Arch. 2018; 472(5):789-796. DOI: 10.1007/s00428-018-2292-6. View

Miettinen M, Felisiak-Golabek A, Wasag B, Chmara M, Wang Z, Butzow R . Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases. Am J Surg Pathol. 2016; 40(12):1661-1669. PMC: 5106328. DOI: 10.1097/PAS.0000000000000703. View

Wheeler K, Warr D, Warsetsky S, Barmat L . Novel fumarate hydratase mutation in a family with atypical uterine leiomyomas and hereditary leiomyomatosis and renal cell cancer. Fertil Steril. 2015; 105(1):144-8. DOI: 10.1016/j.fertnstert.2015.09.034. View

Ooi A . Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research. Semin Cancer Biol. 2019; 61:158-166. PMC: 7078051. DOI: 10.1016/j.semcancer.2019.10.016. View

Rivera-Cruz G, Boyraz B, Petrozza J . How a woman's myomectomy saved her father's life: evidence of fumarate hydratase-deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase. F S Rep. 2022; 3(1):26-31. PMC: 8978059. DOI: 10.1016/j.xfre.2021.10.002. View

10.

Stewart E . Uterine fibroids. Lancet. 2001; 357(9252):293-8. DOI: 10.1016/S0140-6736(00)03622-9. View

11.

Zyla R, Hodgson A . Gene of the month: FH. J Clin Pathol. 2021; 74(10):615-619. DOI: 10.1136/jclinpath-2021-207830. View

12.

Zinn A, Kerr D, Hoppel C . Fumarase deficiency: a new cause of mitochondrial encephalomyopathy. N Engl J Med. 1986; 315(8):469-75. DOI: 10.1056/NEJM198608213150801. View

13.

Bourgeron T, Chretien D, Poggi-Bach J, Doonan S, Rabier D, Letouze P . Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. J Clin Invest. 1994; 93(6):2514-8. PMC: 294471. DOI: 10.1172/JCI117261. View

14.

Harrison W, Andrici J, Maclean F, Madadi-Ghahan R, Farzin M, Sioson L . Fumarate Hydratase-deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings. Am J Surg Pathol. 2015; 40(5):599-607. PMC: 4830748. DOI: 10.1097/PAS.0000000000000573. View

15.

Machado-Lopez A, Simon C, Mas A . Molecular and Cellular Insights into the Development of Uterine Fibroids. Int J Mol Sci. 2021; 22(16). PMC: 8395213. DOI: 10.3390/ijms22168483. View

16.

Tomlinson I, Alam N, Rowan A, Barclay E, Jaeger E, Kelsell D . Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002; 30(4):406-10. DOI: 10.1038/ng849. View

17.

Bayley J, Launonen V, Tomlinson I . The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet. 2008; 9:20. PMC: 2322961. DOI: 10.1186/1471-2350-9-20. View

18.

Sparic R, Mirkovic L, Malvasi A, Tinelli A . Epidemiology of Uterine Myomas: A Review. Int J Fertil Steril. 2016; 9(4):424-35. PMC: 4793163. DOI: 10.22074/ijfs.2015.4599. View